Conference Coverage
Conference Coverage
Rosuvastatin Lessened Endothelial Dysfunction in SSc
Major finding: Rosuvastatin increased low-mediated dilatation in systemic sclerosis from 2.3% to 5.7%.Data source: The data come from a case-...
Conference Coverage
SEARCH Turns Up More Diabetes in Youth
Major Finding: From 2001 to 2009, the prevalence of type 1 diabetes rose 23% among American youth aged 20 years and younger.
Conference Coverage
Aggressive BP Lowering in Diabetes No Boost to CVD Outcomes
Major Finding: Cardiovascular disease outcomes did not vary between people with diabetes mellitus whose blood pressure was treated to less than...
Conference Coverage
Rapid HbA1c Rise in a Child? Intensify Treatment Fast
Major Finding: Blood glucose increased from 5.7% to 7.3% in children with type 2 diabetes who responded to long-term treatment, but rose from 6.4...
Conference Coverage
Early, Aggressive Glucose Control in Prediabetes Key
Major Finding: Compared with 1,096 patients from a multicenter, randomized controlled trial who consistently had prediabetes, the risk of diabetes...
Conference Coverage
Systematic QI Strategies Lift all Boats in Diabetes Care
Conference Coverage
Statin Doesn't Impair Colesevelam's Glucose-Lowering Ability
Conference Coverage
At 2 Years, Resolute Stent Performs Well in Diabetes Patients
Major Finding: Target lesion failure was higher among those with diabetes at 2 years, 9.6% vs. 7.1%.
Conference Coverage
Statins Appear Safe, Even Beneficial, in Cirrhosis
Major Finding: Among patients with advanced liver disease, the hepatic decompensation rate was 38.2% in patients on statin therapy and 50.6% in...
Conference Coverage
Linagliptin Found Effective, Safe in African Americans With Type 2 Diabetes
Conference Coverage
Longer ICD Detection Window Reduces Inappropriate Shocks
Major Finding: The incidence rate ratio of ICD therapy (antitachycardia pacing or shocks) was 37% lower among patients with implantable...